4D Molecular Therapeutics Inc (NAS:FDMT)
$ 11.62 +0.035 (+0.3%) Market Cap: 607.45 Mil Enterprise Value: 237.09 Mil PE Ratio: 0 PB Ratio: 1.34 GF Score: 55/100

4D Molecular Therapeutics Inc at Bank of America Global Healthcare Conference Transcript

May 13, 2026 / 08:40 PM GMT
Release Date Price: $10.45 (+1.06%)


Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

FDMT.OQ - 4D Molecular Therapeutics Inc
4D Molecular Therapeutics Inc at Bank of America Global Healthcare Conference
May 13, 2026 / 08:40PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Here at B of A. Our next presenting company is 4D Molecular Therapeutics.

I have some members from the management team here.

So welcome, guys.

Thank you for joining us.

Maybe we can start with a couple of introductions from your side, and then you can give us a high-level overview of the company. And I know you have some catalysts coming up, especially 2027 is going to be a big year for the company.

So maybe we can start with that. So David, maybe if you want to start?

--------------------------------------------------------------------------------
Unidentified_2 [2]
----------------------------------------------------------
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot